BANK OF AMERICA CORP /DE/ - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 78 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$7,153,779
-19.5%
4,769,186
-14.7%
0.00%0.0%
Q2 2023$8,890,947
+121.8%
5,591,7900.0%0.00%
Q1 2023$4,009,314
+23.8%
5,591,790
-0.0%
0.00%
Q4 2022$3,237,708
+32277.1%
5,591,896
+55529.7%
0.00%
Q3 2022$10,000
+100.0%
10,052
+151.3%
0.00%
Q2 2022$5,000
-87.5%
4,000
-87.1%
0.00%
Q1 2022$40,000
-93.5%
30,889
-91.2%
0.00%
Q4 2021$619,000
+32.5%
351,662
+63.6%
0.00%
Q3 2021$467,000
-57.4%
214,930
-31.3%
0.00%
Q2 2021$1,096,000
-40.6%
312,951
+67.2%
0.00%
Q1 2021$1,846,000
-23.9%
187,183
-16.4%
0.00%
Q4 2020$2,427,000
-39.1%
223,924
-42.1%
0.00%
-100.0%
Q3 2020$3,983,000
-51.9%
386,703
-2.5%
0.00%0.0%
Q2 2020$8,286,000
+2163.9%
396,818
+961.1%
0.00%
Q1 2020$366,000
-68.1%
37,398
-62.5%
0.00%
Q4 2019$1,148,000
+73.2%
99,654
-18.0%
0.00%
Q3 2019$663,000
+51.4%
121,576
+230.2%
0.00%
Q2 2019$438,000
+500.0%
36,816
+163.2%
0.00%
Q1 2019$73,000
-43.0%
13,990
-65.5%
0.00%
Q4 2018$128,000
+50.6%
40,501
+185.8%
0.00%
Q3 2018$85,000
+66.7%
14,171
+48.8%
0.00%
Q2 2018$51,000
-54.1%
9,522
-50.0%
0.00%
Q1 2018$111,000
+484.2%
19,053
+152.4%
0.00%
Q2 2017$19,000
+72.7%
7,548
+85.3%
0.00%
Q1 2017$11,000
-31.2%
4,074
-27.4%
0.00%
Q4 2016$16,000
+433.3%
5,614
+604.4%
0.00%
Q3 2016$3,000
-75.0%
797
-78.8%
0.00%
Q2 2016$12,0003,7570.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders